We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.71B
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$213M |
| 2 |
Cigna
CI
|
+$207M |
| 3 |
Comcast
CMCSA
|
+$164M |
| 4 |
Zoom
ZM
|
+$155M |
| 5 |
Johnson & Johnson
JNJ
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$237M |
| 2 |
TSMC
TSM
|
+$214M |
| 3 |
NVIDIA
NVDA
|
+$138M |
| 4 |
Adobe
ADBE
|
+$133M |
| 5 |
Pultegroup
PHM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Financials | 13.87% |
| 3 | Industrials | 12.52% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Pulse Biosciences
PLSE
$2.96B
| $125K | ﹤0.01% |
11,195
-1,766
| -14% | -$16.6K |
|
2477
Newmark Group
NMRK
$2.52B
| $125K | ﹤0.01% |
12,242
-3,690
| -23% | -$37.6K |
|
|
CNSL
2478
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $123K | ﹤0.01% |
28,017
+5,074
| +22% | +$21.9K |
|
|
ACRE
2479
Ares Commercial Real Estate
ACRE
$256M
| $122K | ﹤0.01% |
+18,314
| New | +$127K |
|
|
CMRC
2480
Commerce.com Inc Series 1
CMRC
$175M
| $121K | ﹤0.01% |
+14,998
| New | +$107K |
|
2481
Adtran
ADTN
$622M
| $120K | ﹤0.01% |
+22,723
| New | +$116K |
|
2482
Douglas Elliman
DOUG
$166M
| $116K | ﹤0.01% |
100,295
+71,703
| +251% | +$90.3K |
|
2483
SoundHound AI
SOUN
$3.25B
| $116K | ﹤0.01% |
29,417
+8,440
| +40% | +$39.1K |
|
2484
Grid Dynamics Holdings
GDYN
$621M
| $116K | ﹤0.01% |
11,003
-1,689
| -13% | -$17.4K |
|
2485
Aldeyra Therapeutics
ALDX
$91.1M
| $115K | ﹤0.01% |
34,781
-70,273
| -67% | -$275K |
|
2486
Larimar Therapeutics
LRMR
$417M
| $113K | ﹤0.01% |
+15,626
| New | +$120K |
|
2487
ALX Oncology
ALXO
$285M
| $109K | ﹤0.01% |
18,079
+6,080
| +51% | +$74.8K |
|
2488
Gogo Inc
GOGO
$432M
| $108K | ﹤0.01% |
+11,277
| New | +$107K |
|
2489
Omeros
OMER
$986M
| $105K | ﹤0.01% |
+25,800
| New | +$92.2K |
|
2490
Cato Corp
CATO
$66.3M
| $102K | ﹤0.01% |
+18,475
| New | +$99.5K |
|
2491
Hecla Mining
HL
$11.8B
| $99.9K | ﹤0.01% |
20,600
+5,395
| +35% | +$28.8K |
|
2492
Opko Health
OPK
$1.04B
| $99.8K | ﹤0.01% |
79,839
-19,600
| -20% | -$25.4K |
|
2493
Amprius Technologies
AMPX
$1.73B
| $99.5K | ﹤0.01% |
+78,314
| New | +$128K |
|
2494
OppFi
OPFI
$749M
| $99.2K | ﹤0.01% |
29,270
-925
| -3% | -$2.81K |
|
2495
SIGA Technologies
SIGA
$210M
| $98.6K | ﹤0.01% |
+12,991
| New | +$106K |
|
2496
Pitney Bowes
PBI
$2.33B
| $97K | ﹤0.01% |
+19,095
| New | +$91.2K |
|
|
AIV
2497
Aimco
AIV
$377M
| $95.1K | ﹤0.01% |
11,741
-7,298
| -38% | -$58.8K |
|
2498
Torrid Holdings
CURV
$249M
| $95K | ﹤0.01% |
12,688
+484
| +4% | +$2.77K |
|
|
EHAB
2499
DELISTED
Enhabit
EHAB
| $94.2K | ﹤0.01% |
+10,951
| New | +$105K |
|
2500
Evolution Petroleum
EPM
$134M
| $93.4K | ﹤0.01% |
17,726
-42,325
| -70% | -$238K |
|
Similar funds
VGA
AQR Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, AQR Capital Management held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Humana, an estimated $237M trimmed.
- AQR Capital Management's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
- AQR Capital Management added most to ExxonMobil in Q2 2024, an estimated $213M increase.
- AQR Capital Management's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
- AQR Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
- AQR Capital Management's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
- AQR Capital Management opened 313 new positions and closed 123 in Q2 2024.
- AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $65.2B.
Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.